A randomized, placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with AZD 1775 (MK 1775) in women with recurrent, platinum-resistant epithelial ovarian, primary peritoneal, or Fallopian tube cancers: Trial of Princess Margaret, Mayo, Chicago, and California consortia.
- Authors:
- S Lheureux, JI Weberpals, AEW Hendrickson, GF Fleming, A Olawaiye, I Brana, H Mackay, NC Dhani, MK Wilson, V Rodriguez-Freixinos, C Martin-Lorente, J Ward, K Chang, L Wang, V Speers, K Karakasis, VL Bowering, A Chen, J Brenton, AM Oza
- Journal:
- JOURNAL OF CLINICAL ONCOLOGY
- Citation info:
- 33(15)
- Publication date:
- 1st Aug 2015
- Full text
- DOI